0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In renal cell carcinoma (RCC), the prediction of metastasis via tumor prognostic markers remains a major problem. The objective of our study was to evaluate the efficacy of cyclin-dependent kinase (CDK)1 and CDK2 activity as a prognostic marker in human RCC.

          Related collections

          Author and article information

          Journal
          Urol. Oncol.
          Urologic oncology
          1873-2496
          1078-1439
          Nov 2014
          : 32
          : 8
          Affiliations
          [1 ] Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan. Electronic address: fhongo@koto.kpu-m.ac.jp.
          [2 ] Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
          [3 ] Central Research Laboratories, Sysmex Corporation, Kobe, Japan.
          [4 ] Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan.
          Article
          S1078-1439(14)00169-0
          10.1016/j.urolonc.2014.05.006
          25443276
          edf70f40-a6bc-4752-bdb3-f0f05ae733b5
          Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.
          History

          Biomarker,Cyclin-dependent kinase,Renal cell carcinoma

          Comments

          Comment on this article